These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9134533)

  • 1. [Monoamines, monoamine metabolites, neuron specific enolase and myelin basic protein concentrations in cerebrospinal fluid of resuscitated patients].
    Takahashi T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Feb; 17(1):7-16. PubMed ID: 9134533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-specific enolase and myelin basic protein: relationship of cerebrospinal fluid concentrations to the neurologic condition of asphyxiated full-term infants.
    Garcia-Alix A; Cabañas F; Pellicer A; Hernanz A; Stiris TA; Quero J
    Pediatrics; 1994 Feb; 93(2):234-40. PubMed ID: 7510064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Age changes in concentrations of monoamines and related substances in the cerebrospinal fluid].
    Takahashi S; Abe T
    No To Shinkei; 1991 Apr; 43(4):331-6. PubMed ID: 1716119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
    Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
    Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.
    Berger RP; Adelson PD; Pierce MC; Dulani T; Cassidy LD; Kochanek PM
    J Neurosurg; 2005 Jul; 103(1 Suppl):61-8. PubMed ID: 16122007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamines in the brain cerebrospinal fluid of facial pain patients.
    Bouckoms AJ; Sweet WH; Poletti C; Lavori P; Carr D; Matson W; Gamache P; Aronin N
    Anesth Prog; 1992; 39(6):201-8. PubMed ID: 7504420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum neuron-specific enolase as early predictor of outcome after in-hospital cardiac arrest: a cohort study.
    Rech TH; Vieira SR; Nagel F; Brauner JS; Scalco R
    Crit Care; 2006; 10(5):R133. PubMed ID: 16978415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of neuron specific enolase and S100 protein in evaluation of brain damage in patients resuscitated from cardiac arrest].
    Miao WL; Li HL; Wang HD; Wang J; Liu H; Ren HX; Lin HY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):749-52. PubMed ID: 18093437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale.
    Pfeifer R; Börner A; Krack A; Sigusch HH; Surber R; Figulla HR
    Resuscitation; 2005 Apr; 65(1):49-55. PubMed ID: 15797275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.
    Beems T; Simons KS; Van Geel WJ; De Reus HP; Vos PE; Verbeek MM
    Acta Neurochir (Wien); 2003 Jan; 145(1):37-43. PubMed ID: 12545260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
    Poceta JS; Parsons L; Engelland S; Kripke DF
    Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
    J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen.
    Satoh H; Yamato O; Asano T; Yonemura M; Yamauchi T; Hasegawa D; Orima H; Arai T; Yamasaki M; Maede Y
    Brain Res; 2007 Feb; 1133(1):200-8. PubMed ID: 17196562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling.
    Geracioti TD; Loosen PT; Ekhator NN; Schmidt D; Chambliss B; Baker DG; Kasckow JW; Richtand NM; Keck PE; Ebert MH
    Depress Anxiety; 1997; 6(3):89-94. PubMed ID: 9442982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid levels of monoamine compounds and cholecystokinin peptides after exposure to standardized barometric pressure.
    Eklundh T; Gunnarsson T; Ornhagen H; Nordin C
    Aviat Space Environ Med; 2000 Nov; 71(11):1131-6. PubMed ID: 11086668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic pitfalls in patients with hypoxic brain damage: three case reports.
    Zingler VC; Pohlmann-Eden B
    Resuscitation; 2005 Apr; 65(1):107-10. PubMed ID: 15797283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome].
    Takano K; Ishiguro T
    Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.